Verition Fund Management LLC Cor Medix Inc. Transaction History

Verition Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.08 - $6.39 $55,585 - $87,057	13,624 New	13,624 $58,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $75,600 - $93,660	21,000 New	21,000 $77,000
Q2 2019 Aug 14, 2019	SELL	$5.93 - $10.57 $83,684 - $149,163	-14,112 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$6.95 - $13.25 $98,078 - $186,984	14,112 New	14,112 $133,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.